[HTML] frontiersin.org

[HTML][HTML] Inhibition of HDAC6 with CAY10603 ameliorates diabetic kidney disease by suppressing NLRP3 inflammasome

Q Hou, S Kan, Z Wang, J Shi, C Zeng, D Yang… - Frontiers in …, 2022 - frontiersin.org
Background: Diabetic nephropathy (DN) is one of the leading causes of chronic kidney
disease (CKD) worldwide, tubular injury is the driving force during the pathogenesis and …
被引用次数：18 相关文章
[HTML] nih.gov

[HTML][HTML] Inhibition of HDAC6 With CAY10603 Ameliorates Diabetic Kidney Disease by Suppressing NLRP3 Inflammasome

Q Hou, S Kan, Z Wang, J Shi, C Zeng… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Background: Diabetic nephropathy (DN) is one of the leading causes of chronic kidney
disease (CKD) worldwide, tubular injury is the driving force during the pathogenesis and …

Inhibition of HDAC6 With CAY10603 Ameliorates Diabetic Kidney Disease by Suppressing NLRP3 Inflammasome

Q Hou, S Kan, Z Wang, J Shi, C Zeng… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Background: Diabetic nephropathy (DN) is one of the leading causes of chronic kidney
disease (CKD) worldwide, tubular injury is the driving force during the pathogenesis and …

Inhibition of HDAC6 With CAY10603 Ameliorates Diabetic Kidney Disease by Suppressing NLRP3 Inflammasome.

Q Hou, S Kan, Z Wang, J Shi, C Zeng… - Frontiers in …, 2022 - europepmc.org
Background: Diabetic nephropathy (DN) is one of the leading causes of chronic kidney
disease (CKD) worldwide, tubular injury is the driving force during the pathogenesis and …